Compass Therapeutics Company
Compass Therapeutics is a biopharmaceutical company focused on drugging the immune system to treat human diseases.
Investors
Technology:
Personalised Medicine
Industry:
P4 Medicine
Headquarters:
United States
Investors Number:
6
Total Funding:
$55.6M
Estimated Revenue:
$1M to $10M
Last Funding Type:
Grant
Register and Claim Ownership